Acute Severe Ulcerative Colitis: Clinical Trials

5 trials for Acute Severe Ulcerative Colitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 2 recruiting, 1 completed. 2 Phase 4, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 42Recruiting 2
Not applicable1Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow Acute Severe Ulcerative Colitis: new trials by email Literature Review of Acute Severe Ulcerative Colitis trials Research Report on Acute Severe Ulcerative Colitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis(UPRISE)
upadacitinib, Infliximab - Acute Severe Ulcerative Colitis
Phase 4RecruitingXijing Hospital of Digestive Diseases2262026-04-202026-04-24
Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis(UPFRONT)
Upadacitinib, Corticosteroid - Acute Severe Ulcerative Colitis
Phase 4RecruitingYongquan Shi462026-03-232026-06-15
Combination Therapy With Infliximab and Tofacitinib for Acute Severe Ulcerative Colitis - CINTO Trial
Infliximab, Tofacitinib - Acute Severe Ulcerative Colitis
Phase 2Not yet recruitingAsian Institute of Gastroenterology, India602026-01-012025-12-24
Cohort of Patients With Ulcerative Colitis or Polyps Followed in CHU de Bordeaux Associated With a Biocollection - COLIBRI
Blood sample, biopsy - Ulcerative Colitis, Inflammatory Bowel Disease (IBD)
Not applicableNot yet recruitingUniversity Hospital, Bordeaux2002025-09-012025-07-24
Effectiveness and Safety of Upadacitinib for Acute Severe Ulcerative Colitis
Upadacitinib - Ulcerative Colitis (UC), Acute Severe Ulcerative Colitis
CompletedXijing Hospital of Digestive Diseases812023-06-062026-03-16

Narrower conditions

Colitis, Ulcerative (2)  ·  Inflammatory Bowel Diseases (1)

Broader conditions

Colitis (2)  ·  Colonic Diseases (2)  ·  Digestive System Diseases (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)  ·  Inflammatory Bowel Diseases (1)

Interventions

upadacitinib (3)  ·  Infliximab (2)  ·  Adrenal Cortex Hormones (1)  ·  Biopsy (1)  ·  Blood Specimen Collection (1)  ·  tofacitinib (1)

Sponsors

Xijing Hospital of Digestive Diseases (2)  ·  Asian Institute of Gastroenterology, India (1)  ·  University Hospital, Bordeaux (1)  ·  Yongquan Shi (1)

Countries

China (3)  ·  France (1)  ·  India (1)

Top investigators

Vamsi Krishna Ankam, DrNB(gastroenterology) (1)